RGORX
Price
$24.52
Change
-$0.24 (-0.97%)
Updated
Jul 13 closing price
Net Assets
450.09M
RNPCX
Price
$71.64
Change
-$0.96 (-1.32%)
Updated
Jul 13 closing price
Net Assets
170.23B
Interact to see
Advertisement

RGORX vs RNPCX

RGORX vs RNPCX Comparison Chart in %
View a ticker or compare two or three
VS
RGORX vs. RNPCX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGORX is a StrongBuy and RNPCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 170B vs. RGORX (450M). RNPCX pays higher dividends than RGORX: RNPCX (0.70) vs RGORX (0.42). RGORX was incepted earlier than RNPCX: RGORX (10 years) vs RNPCX (24 years). RNPCX (1.05) is less costly to investors than RGORX (0.73). RGORX is a more actively managed with annual turnover of: 79.00 vs. RNPCX (23.00). RNPCX has a lower initial minimum investment than RGORX: RNPCX (250) vs RGORX (250000). RGORX annual gain was more profitable for investors over the last year : 9.65 vs. RNPCX (6.93). RGORX return over 5 years is better than : 17.08 vs. RNPCX (11.29).
RGORXRNPCXRGORX / RNPCX
Total Expense Ratio0.701.0567%
Annual Report Gross Expense Ratio0.731.0570%
Fund Existence10 years24 years-
Gain YTD2.3565.15246%
Front LoadN/AN/A-
Min. Initial Investment250000250100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets450M170B0%
Annual Yield % from dividends0.420.7060%
Returns for 1 year9.656.93139%
Returns for 3 years42.7732.65131%
Returns for 5 years17.0811.29151%
Returns for 10 yearsN/A103.71-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HIEMX7.77N/A
N/A
Virtus SGA Emerging Markets Equity I
VESIX47.21N/A
N/A
Vanguard European Stock Instl
FSGAX48.69N/A
N/A
Franklin Small-Mid Cap Growth Adv
FBTDX177.71N/A
N/A
Franklin Biotechnology Discovery C
TSLTX6.45N/A
N/A
Transamerica Small Cap Value I3